Correlation Between Walker Dunlop and CorMedix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and CorMedix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and CorMedix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and CorMedix, you can compare the effects of market volatilities on Walker Dunlop and CorMedix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of CorMedix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and CorMedix.

Diversification Opportunities for Walker Dunlop and CorMedix

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Walker and CorMedix is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and CorMedix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CorMedix and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with CorMedix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CorMedix has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and CorMedix go up and down completely randomly.

Pair Corralation between Walker Dunlop and CorMedix

Allowing for the 90-day total investment horizon Walker Dunlop is expected to under-perform the CorMedix. But the stock apears to be less risky and, when comparing its historical volatility, Walker Dunlop is 2.37 times less risky than CorMedix. The stock trades about 0.0 of its potential returns per unit of risk. The CorMedix is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,005  in CorMedix on August 31, 2024 and sell it today you would lose (7.00) from holding CorMedix or give up 0.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Walker Dunlop  vs.  CorMedix

 Performance 
       Timeline  
Walker Dunlop 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Walker Dunlop are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, Walker Dunlop may actually be approaching a critical reversion point that can send shares even higher in December 2024.
CorMedix 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CorMedix are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain primary indicators, CorMedix exhibited solid returns over the last few months and may actually be approaching a breakup point.

Walker Dunlop and CorMedix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Walker Dunlop and CorMedix

The main advantage of trading using opposite Walker Dunlop and CorMedix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, CorMedix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CorMedix will offset losses from the drop in CorMedix's long position.
The idea behind Walker Dunlop and CorMedix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments